Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6139312B2 - - Google Patents
[go: Go Back, main page]

JPS6139312B2 - - Google Patents

Info

Publication number
JPS6139312B2
JPS6139312B2 JP13447084A JP13447084A JPS6139312B2 JP S6139312 B2 JPS6139312 B2 JP S6139312B2 JP 13447084 A JP13447084 A JP 13447084A JP 13447084 A JP13447084 A JP 13447084A JP S6139312 B2 JPS6139312 B2 JP S6139312B2
Authority
JP
Japan
Prior art keywords
chloroform
water
residue
benzoxazine
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13447084A
Other languages
Japanese (ja)
Other versions
JPS6034968A (en
Inventor
Isao Hayakawa
Tokyuki Hiramitsu
Yoshiaki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP13447084A priority Critical patent/JPS6034968A/en
Publication of JPS6034968A publication Critical patent/JPS6034968A/en
Publication of JPS6139312B2 publication Critical patent/JPS6139312B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は式 で表わされるピリド〔1,2,3―de〕〔1,
4〕ベンゾオキサジン誘導体およびその塩に関す
るものである。 塩としては、塩酸、硫酸、メタンスルホン酸の
如き無機もしくは有機酸との塩、あるいはカルボ
ン酸のナトリウム塩やカリウム塩が具体例として
挙げられる。 本発明化合物に類似の構造を有する化合物とし
ては、特開昭50―108298号、特開昭51―127099号
または特開昭55―76875号公報に記載されたもの
があるが、これらのいずれよりも本発明化合物は
著しく優れた活性を示す。 本発明化合物の製造法の例を反応式で示して説
明する。 すなわち、化合物〔〕をジメチルスルホキシ
ド、スルホラン、ジメチルホルムアミド、ジメチ
ルアセトアミド、水の如き極性溶媒中でN―メチ
ルピペラジンと室温ないし200℃、好ましくは70
〜150℃で1時間ないし48時間加熱することによ
つて化合物〔〕が得られる。 本発明の化合物およびその塩は、緑膿菌を含む
グラム陰性菌およびグラム陽性菌に対して強い抗
菌作用を示し、医薬品としての使用が期待でき
る。例えば、医薬品として使用されているピペミ
ド酸を対照として試験管内抗菌試験において、最
小発育阻止濃度を測定した結果は次表に示すよう
に優れた抗菌活性を示す。 最小発育阻止濃度(MIC,μg/ml) 平板希釈法(ハートインフユージヨン寒天培
地) 接種菌量 106/ml 培養条件 37℃,18時間
The present invention is based on the formula Pyrido [1,2,3-de] [1,
4] Concerning benzoxazine derivatives and salts thereof. Specific examples of the salt include salts with inorganic or organic acids such as hydrochloric acid, sulfuric acid, and methanesulfonic acid, and sodium and potassium salts of carboxylic acids. Compounds having a structure similar to the compound of the present invention include those described in JP-A-50-108298, JP-A-51-127099, and JP-A-55-76875. The compounds of the present invention also exhibit extremely excellent activity. An example of the method for producing the compound of the present invention will be explained using a reaction formula. That is, the compound [] is mixed with N-methylpiperazine in a polar solvent such as dimethylsulfoxide, sulfolane, dimethylformamide, dimethylacetamide, or water at room temperature to 200°C, preferably at 70°C.
Compound [] is obtained by heating at ~150°C for 1 to 48 hours. The compounds of the present invention and their salts exhibit strong antibacterial activity against Gram-negative bacteria and Gram-positive bacteria, including Pseudomonas aeruginosa, and can be expected to be used as pharmaceuticals. For example, the minimum inhibitory concentration was measured in an in vitro antibacterial test using pipemidic acid, which is used as a pharmaceutical, as a control, and the results show excellent antibacterial activity as shown in the table below. Minimum inhibitory concentration (MIC, μg/ml) Plate dilution method (heart infusion agar medium) Inoculum amount 10 6 /ml Culture conditions 37℃, 18 hours

【表】【table】

【表】 次に参考例および実施例を記載する。 参考例 2,4―ジクロロ―3―フルオロニトロベンゼ
ン5.0gおよび粉末フツ化カリウム5.8gをジメチ
ルスルホキシド5mlに加えて140〜155℃で4.5時
間撹拌する。減圧下に溶媒を留去し、残渣を水と
クロロホルムで分配する。クロロホルム層は水洗
し、乾燥後、クロロホルムを留去して油状物の
2,3,4―トリフルオロニトロベンゼン3.8g
を得る。 このものの20gをジメチルスルホキシド150ml
にとかし、18〜20℃で10%水酸化カリウム水溶液
50mlを滴下する。更に室温で2時間撹拌し、水1
を加えてクロロホルムと振とうする。水層は塩
酸々性としてクロロホルムで抽出し、抽出液は水
洗し、乾燥したのちクロロホルムを濃縮する。残
渣をシリカゲルクロマトグラフイーで精製し、黄
色油状物として2,3―ジフルオロ―6―ニトロ
フエノール5.8gを得る。 このもの5.8gをモノクロロアセトン5.0g,炭
酸カリウム8.0gおよびヨウ化カリウム0.8gとア
セトン100mlに加えて4時間還流する。不溶物を
濾去し、溶媒を留去して、残渣をクロロホルムと
水で分配する。クロロホルム層は水洗し、乾燥し
たのち、溶媒を留去して残渣をn―ヘキサンで処
理し、淡黄白色結晶として2―アセトニルオキシ
―3,4―ジフルオロニトロベンゼン5.0gを得
る。 このもの7.1gをエタノール200mlにとかし、ラ
ネーニツケル14mlを加えて常圧接触還元する。触
媒を濾去し、溶媒を留去したのち、残渣をシリカ
ゲルの層を通じて脱色すると、7,8′―ジフルオ
ロ―2,3―ジヒドロ―3―メチル―4H―
〔1,4〕ベンゾオキサジンを淡黄色油状物とし
て5.1g得ることが出来る。 このものの4.8gおよびエトキシメチレンマロ
ン酸ジエチル5.3gの混合物を140〜145℃で1時
間加熱する。原料消失後少量のエタノールを減圧
留去し、得られる油状物にポリリン酸エチル35g
を加え、浴温140〜145℃で1時間撹拌する。冷後
氷水に注ぎ、析出沈殿をクロロホルム600ml(200
×3)で抽出する。クロロホルム層を5%炭酸カ
リウム水溶液次いで水で分配後、芒硝で乾燥し、
9,10―ジフルオロ―3―メチル―7―オキソ―
2,3―ジヒドロ―7H―ピリド〔1,2,3―
de〕〔1,4〕ベンゾオキサジン―6―カルボン
酸エチルエステルの白色粉末5.1gを得る。融点
261℃。 このものの4.0gを濃塩酸―酢酸(1:4)50
mlに溶解し、油浴にて3時間還流する。冷後析出
晶を濾取し、充分水洗後、エタノール―エーテル
(1:4)の混液で洗い、減圧乾燥して透明板状
晶の9,10―ジフルオロ―3―メチル―7―オキ
ソ―2,3―ジヒドロ―7H―ピリド〔1,2,
3―de〕〔1,4〕ベンゾオキサジン―6―カル
ボン酸3.7gを得る。融点>300℃。 NMR(CF3COOH)δppm: 1.88(3H,d,C3―CH3) 4.72(2H,b.s.C2―H2) 4.8〜5.1(1H,m,C3―H) 7.9〜8.2(1H,q,C8―H) 9.42(1H,s,C5―H) 実施例 9,10―ジフルオロ―3―メチル―7―オキソ
―2,3―ジヒドロ―7H―ピリド〔1,2,3
―de〕〔1,4〕ベンゾオキサジン―6―カルボ
ン酸1.0gおよびN―メチルピペラジン2.85gを
ジメチルスルホキシド15mlに加え、100〜110℃で
12時間撹拌する。反応混合物を減圧乾固し、残渣
に水40mlを加えてクロロホルムで抽出する。抽出
液を乾燥後、減圧乾固し、残渣をエタノールから
再結晶すると融点250〜257℃(分解)の無色針状
晶として9―フルオロ―3―メチル―10―(4―
メチル―1―ピペラジニル)―7―オキソ―2,
3―ジヒドロ―7H―ピリド〔1,2,3―de〕
〔1,4〕ベンゾオキサジン―6―カルボン酸550
mgを得る。 元素分析値C18H20FN3O4として 計算値 C59.82,H5.58,N11.63 分析値 C59.62,H5.59,N11.651 H―NMR(CDCl3)δppm: 1.63(3H,d,J=7Hz,C3―CH3 ) 2.38(3H,s,N―CH3 ) 2.54〜2.60(4H,m,
[Table] Next, reference examples and examples are described. Reference example 5.0 g of 2,4-dichloro-3-fluoronitrobenzene and 5.8 g of powdered potassium fluoride are added to 5 ml of dimethyl sulfoxide and stirred at 140-155°C for 4.5 hours. The solvent was removed under reduced pressure and the residue was partitioned between water and chloroform. The chloroform layer was washed with water, dried, and the chloroform was distilled off to obtain 3.8 g of 2,3,4-trifluoronitrobenzene as an oily substance.
get. 20g of this and 150ml of dimethyl sulfoxide
Mix with 10% potassium hydroxide aqueous solution at 18-20℃
Drop 50ml. Stir further at room temperature for 2 hours, then add 1 liter of water.
Add chloroform and shake. The aqueous layer is diluted with hydrochloric acid and extracted with chloroform. The extract is washed with water, dried, and the chloroform is concentrated. The residue is purified by silica gel chromatography to obtain 5.8 g of 2,3-difluoro-6-nitrophenol as a yellow oil. Add 5.8 g of this product to 5.0 g of monochloroacetone, 8.0 g of potassium carbonate, 0.8 g of potassium iodide, and 100 ml of acetone, and reflux for 4 hours. Insoluble materials are filtered off, the solvent is distilled off, and the residue is partitioned between chloroform and water. The chloroform layer is washed with water, dried, and then the solvent is distilled off and the residue is treated with n-hexane to obtain 5.0 g of 2-acetonyloxy-3,4-difluoronitrobenzene as pale yellow-white crystals. Dissolve 7.1 g of this product in 200 ml of ethanol, add 14 ml of Raney nickel, and perform atmospheric pressure catalytic reduction. After filtering off the catalyst and distilling off the solvent, the residue was decolorized through a layer of silica gel to give 7,8'-difluoro-2,3-dihydro-3-methyl-4H-
5.1 g of [1,4]benzoxazine can be obtained as a pale yellow oil. A mixture of 4.8 g of this and 5.3 g of diethyl ethoxymethylenemalonate is heated at 140-145°C for 1 hour. After the raw materials disappeared, a small amount of ethanol was distilled off under reduced pressure, and 35 g of ethyl polyphosphate was added to the resulting oil.
and stir for 1 hour at a bath temperature of 140-145°C. After cooling, pour into ice water and dissolve the precipitate in chloroform 600ml (200ml).
×3) Extract. After partitioning the chloroform layer with a 5% aqueous potassium carbonate solution and then water, it was dried with Glauber's salt,
9,10-difluoro-3-methyl-7-oxo-
2,3-dihydro-7H-pyrido [1,2,3-
5.1 g of white powder of de][1,4]benzoxazine-6-carboxylic acid ethyl ester was obtained. melting point
261℃. Add 4.0g of this to concentrated hydrochloric acid-acetic acid (1:4)50
ml and reflux for 3 hours in an oil bath. After cooling, the precipitated crystals were collected by filtration, thoroughly washed with water, washed with a mixture of ethanol and ether (1:4), and dried under reduced pressure to obtain transparent plate-like crystals of 9,10-difluoro-3-methyl-7-oxo-2. ,3-dihydro-7H-pyrido [1,2,
3.7 g of 3-de][1,4]benzoxazine-6-carboxylic acid is obtained. Melting point >300℃. NMR (CF 3 COOH) δppm: 1.88 (3H, d, C 3 - CH 3 ) 4.72 (2H, bsC 2 - H 2 ) 4.8 - 5.1 (1H, m, C 3 - H) 7.9 - 8.2 (1H, q , C 8 -H) 9.42 (1H, s, C 5 -H) Example 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3
-de] [1,4] 1.0 g of benzoxazine-6-carboxylic acid and 2.85 g of N-methylpiperazine were added to 15 ml of dimethyl sulfoxide, and the mixture was heated at 100 to 110°C.
Stir for 12 hours. The reaction mixture was dried under reduced pressure, 40 ml of water was added to the residue, and the mixture was extracted with chloroform. After drying the extract, it was dried under reduced pressure and the residue was recrystallized from ethanol to give 9-fluoro-3-methyl-10-(4-
Methyl-1-piperazinyl)-7-oxo-2,
3-dihydro-7H-pyrido [1,2,3-de]
[1,4]Benzoxazine-6-carboxylic acid 550
Get mg. Elemental analysis value C 18 H 20 FN 3 O 4 Calculated value C59.82, H5.58, N11.63 Analysis value C59.62, H5.59, N11.65 1 H-NMR (CDCl 3 ) δppm: 1.63 ( 3H, d, J = 7Hz, C 3 - C H 3 ) 2.38 (3H, s, N - C H 3 ) 2.54 - 2.60 (4H, m,

【式】 3.40〜3.44(4H,m,【formula】 3.40~3.44 (4H, m,

【式】 4.35〜4.51(3H,m,C3およびC2H2 ) 7.75(1H,d,J=12Hz,C8) 8.64(1H,s,C5)。[Formula] 4.35-4.51 (3H, m, C3 - H and C2 - H2 ) 7.75 (1H, d, J=12Hz, C8 - H ) 8.64 (1H, s, C5 - H ).

Claims (1)

【特許請求の範囲】 1 9―フルオロ―10―(4―メチル―1―ピペ
ラジニル)―7―オキソ―2,3―ジヒドロ―
7H―ピリド〔1,2,3―de〕〔1,4〕ベンゾ
オキサジン―6―カルボン酸およびその塩。
[Claims] 1 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-
7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid and its salts.
JP13447084A 1984-06-29 1984-06-29 Pyrido(1,2,3-de)(1,4)benzoxazine derivative Granted JPS6034968A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13447084A JPS6034968A (en) 1984-06-29 1984-06-29 Pyrido(1,2,3-de)(1,4)benzoxazine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13447084A JPS6034968A (en) 1984-06-29 1984-06-29 Pyrido(1,2,3-de)(1,4)benzoxazine derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP55121540A Division JPS5746986A (en) 1980-09-02 1980-09-02 Pyrido(1,2,3-de)(1,4)benzoxazine derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP1225487A Division JPS62187473A (en) 1987-01-23 1987-01-23 Pyridobenzoxazine derivative

Publications (2)

Publication Number Publication Date
JPS6034968A JPS6034968A (en) 1985-02-22
JPS6139312B2 true JPS6139312B2 (en) 1986-09-03

Family

ID=15129071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13447084A Granted JPS6034968A (en) 1984-06-29 1984-06-29 Pyrido(1,2,3-de)(1,4)benzoxazine derivative

Country Status (1)

Country Link
JP (1) JPS6034968A (en)

Also Published As

Publication number Publication date
JPS6034968A (en) 1985-02-22

Similar Documents

Publication Publication Date Title
EP0117474A1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
JPH0148911B2 (en)
SU566524A3 (en) Method of obtaining derivatives of pyrido-(1,2-alpha)-pyrimidine and their salts
SU1314954A3 (en) Method for producing quinolinecarboxylic acid derivatives or acid-additive salts thereof
JPH027314B2 (en)
JPH0134219B2 (en)
JPH0116837B2 (en)
JPS6139312B2 (en)
SU1322980A3 (en) Method of producing derivatives of 7-(pyrrole-1-yl)-1-ethyl-1,4-dihydro-4-oxo-quinolein-3-carboxylic and 7-(pyrrole-1-yl)-1-ethyl-1,4-dihydro-4-oxo-(1,8-naphthyridene)-3-carboxylic acids
JPS6256154B2 (en)
JPS6232753B2 (en)
SU567402A3 (en) Method of preparation of quinoline derivatives and salts thereof
JPS6072885A (en) Quinoline derivative
CH578535A5 (en) Quinoline-3-carboxylic acid derivs - with e.g. analgesic, antinociceptive, antiinflammatory and antiallergic props
EP0596963A1 (en) PROCESS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF SUBSTITUTED 6-(3,5,6,7-TETRAHYDROPYRROLO 2,1-c] 1,2,4]THIADIAZOLE-3-YLIDENAMINO)-7-FLUORO-2H-1,4-BENZOXAZIN-3(4H)-ONES
JPS5944312B2 (en) Production method of indazole derivatives
AT344153B (en) PROCESS FOR THE PREPARATION OF NEW 2-ALKYL-5-INDANACETIC ACID AND ALKYLESTER DERIVATIVES
JPH0124153B2 (en)
JPS58225092A (en) Pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid derivative
JPS58135840A (en) 2,3-difluoro-6-nitrophenol
SU1068417A1 (en) Process for preparing derivatives of 1,2-dioxo-3-chloronaphthalene or 4,5-dioxoindole
SU421186A3 (en) Method of producing 17-aza-16-keto-steroids derivatives
FR2476648A1 (en) PROCESS FOR THE PREPARATION OF 5-CYANO- (3,4'-BIPYRIDINE) -6 (1H) ONE
JPS6237638B2 (en)
JPH07228556A (en) Method for producing 2-aminobenzyl alcohol derivative